2pld: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:
|PDB= 2pld |SIZE=350|CAPTION= <scene name='initialview01'>2pld</scene>
|PDB= 2pld |SIZE=350|CAPTION= <scene name='initialview01'>2pld</scene>
|SITE=  
|SITE=  
|LIGAND= <scene name='pdbligand=PO3:PHOSPHITE ION'>PO3</scene>
|LIGAND= <scene name='pdbligand=PO3:PHOSPHITE+ION'>PO3</scene>
|ACTIVITY= [http://en.wikipedia.org/wiki/Phosphoinositide_phospholipase_C Phosphoinositide phospholipase C], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.4.11 3.1.4.11]  
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Phosphoinositide_phospholipase_C Phosphoinositide phospholipase C], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.4.11 3.1.4.11] </span>
|GENE=  
|GENE=  
|DOMAIN=
|RELATEDENTRY=[[2ple|2PLE]]
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2pld FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2pld OCA], [http://www.ebi.ac.uk/pdbsum/2pld PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2pld RCSB]</span>
}}
}}


Line 14: Line 17:
==Overview==
==Overview==
The solution structure of the C-terminal SH2 domain of phospholipase C-gamma 1 (PLC-gamma 1), in complex with a phosphopeptide corresponding to its Tyr-1021 high affinity binding site on the platelet-derived growth factor receptor, has been determined by nuclear magnetic resonance spectroscopy. The topology of the SH2-phosphopeptide complex is similar to previously reported Src and Lck SH2 complexes. However, the binding site for residues C-terminal to the phosphotyrosine (pTyr) is an extended groove that contacts peptide residues at the +1 to +6 positions relative to the pTyr. This striking difference from Src and Lck reflects the fact that the PLC-gamma 1 complex involves binding of a phosphopeptide with predominantly hydrophobic residues C-terminal to the pTyr and therefore serves as a prototype for a second class of SH2-phosphopeptide interactions.
The solution structure of the C-terminal SH2 domain of phospholipase C-gamma 1 (PLC-gamma 1), in complex with a phosphopeptide corresponding to its Tyr-1021 high affinity binding site on the platelet-derived growth factor receptor, has been determined by nuclear magnetic resonance spectroscopy. The topology of the SH2-phosphopeptide complex is similar to previously reported Src and Lck SH2 complexes. However, the binding site for residues C-terminal to the phosphotyrosine (pTyr) is an extended groove that contacts peptide residues at the +1 to +6 positions relative to the pTyr. This striking difference from Src and Lck reflects the fact that the PLC-gamma 1 complex involves binding of a phosphopeptide with predominantly hydrophobic residues C-terminal to the pTyr and therefore serves as a prototype for a second class of SH2-phosphopeptide interactions.
==Disease==
Known diseases associated with this structure: Myelomonocytic leukemia, chronic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=173410 173410]], Myeloproliferative disorder with eosinophilia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=173410 173410]]


==About this Structure==
==About this Structure==
Line 34: Line 34:
[[Category: Singer, A U.]]
[[Category: Singer, A U.]]
[[Category: Yamazaki, T.]]
[[Category: Yamazaki, T.]]
[[Category: PO3]]
[[Category: phosphoric diester hydrolase]]
[[Category: phosphoric diester hydrolase]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 18:14:27 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 04:37:31 2008''